179 related articles for article (PubMed ID: 34151251)
1. Drug crystal growth in ternary amorphous solid dispersions: Effect of surfactants and polymeric matrix-carriers.
Kapourani A; Tzakri T; Valkanioti V; Kontogiannopoulos KN; Barmpalexis P
Int J Pharm X; 2021 Dec; 3():100086. PubMed ID: 34151251
[TBL] [Abstract][Full Text] [Related]
2. Preparation and Evaluation of Amorphous Solid Dispersions for Enhancing Luteolin's Solubility in Simulated Saliva.
Koromili M; Kapourani A; Barmpalexis P
Polymers (Basel); 2022 Dec; 15(1):. PubMed ID: 36616519
[TBL] [Abstract][Full Text] [Related]
3. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: stability testing of selected solid dispersions.
Ghebremeskel AN; Vemavarapu C; Lodaya M
Pharm Res; 2006 Aug; 23(8):1928-36. PubMed ID: 16871443
[TBL] [Abstract][Full Text] [Related]
4. Preparation and Evaluation of Siderol Amorphous Solid Dispersions: Selection of Suitable Matrix/Carrier.
Koromili M; Kapourani A; Koletti A; Papandreou G; Assimopoulou AN; Lazari D; Barmpalexis P
AAPS PharmSciTech; 2022 Aug; 23(6):214. PubMed ID: 35918468
[TBL] [Abstract][Full Text] [Related]
5. Synergistic and antagonistic effects of various amphiphilic polymer combinations in enhancing griseofulvin release from ternary amorphous solid dispersions.
Rahman M; Coelho A; Tarabokija J; Ahmad S; Radgman K; Bilgili E
Eur J Pharm Sci; 2020 Jul; 150():105354. PubMed ID: 32380151
[TBL] [Abstract][Full Text] [Related]
6. Rivaroxaban polymeric amorphous solid dispersions: Moisture-induced thermodynamic phase behavior and intermolecular interactions.
Kapourani A; Vardaka E; Katopodis K; Kachrimanis K; Barmpalexis P
Eur J Pharm Biopharm; 2019 Dec; 145():98-112. PubMed ID: 31698042
[TBL] [Abstract][Full Text] [Related]
7. Preparation of a ternary amorphous solid dispersion using hot-melt extrusion for obtaining a stable colloidal dispersion of amorphous probucol nanoparticles.
Hanada N; Higashi K; Zhao Z; Ueda K; Moribe K
Int J Pharm; 2023 Jun; 640():122959. PubMed ID: 37086931
[TBL] [Abstract][Full Text] [Related]
8. Crystallization tendency of APIs possessing different thermal and glass related properties in amorphous solid dispersions.
Kapourani A; Vardaka E; Katopodis K; Kachrimanis K; Barmpalexis P
Int J Pharm; 2020 Apr; 579():119149. PubMed ID: 32070762
[TBL] [Abstract][Full Text] [Related]
9. Effects of Surfactants on Itraconazole-HPMCAS Solid Dispersion Prepared by Hot-Melt Extrusion I: Miscibility and Drug Release.
Solanki NG; Lam K; Tahsin M; Gumaste SG; Shah AV; Serajuddin ATM
J Pharm Sci; 2019 Apr; 108(4):1453-1465. PubMed ID: 30395834
[TBL] [Abstract][Full Text] [Related]
10. An investigation into the role of polymeric carriers on crystal growth within amorphous solid dispersion systems.
Tian Y; Jones DS; Andrews GP
Mol Pharm; 2015 Apr; 12(4):1180-92. PubMed ID: 25692314
[TBL] [Abstract][Full Text] [Related]
11. Drug Amorphous Solid Dispersions Based on Poly(vinyl Alcohol): Evaluating the Effect of Poly(propylene Succinate) as Plasticizer.
Kapourani A; Palamidi A; Kontogiannopoulos KN; Bikiaris ND; Barmpalexis P
Polymers (Basel); 2021 Aug; 13(17):. PubMed ID: 34502962
[TBL] [Abstract][Full Text] [Related]
12. Stability and Bioavailability Enhancement of Telmisartan Ternary Solid Dispersions: the Synergistic Effect of Polymers and Drug-Polymer(s) Interactions.
Shi X; Xu T; Huang W; Fan B; Sheng X
AAPS PharmSciTech; 2019 Mar; 20(4):143. PubMed ID: 30887265
[TBL] [Abstract][Full Text] [Related]
13. Characterization of amorphous celecoxib mixed with plasticizing (TPGS) and anti-plasticizing (PVP) ingredients using Hot Melt Extrusion.
Santiago D; Mendoza A; Morales Z; Santos J
J Pharm Innov; 2020 Sep; 15(3):357-364. PubMed ID: 33343766
[TBL] [Abstract][Full Text] [Related]
14. Investigation into Intermolecular Interactions and Phase Behavior of Binary and Ternary Amorphous Solid Dispersions of Ketoconazole.
Sarpal K; Tower CW; Munson EJ
Mol Pharm; 2020 Mar; 17(3):787-801. PubMed ID: 31860316
[TBL] [Abstract][Full Text] [Related]
15. Experimental, Thermodynamic, and Molecular Modeling Evaluation of Amorphous Simvastatin-Poly(vinylpyrrolidone) Solid Dispersions.
Kapourani A; Chatzitheodoridou M; Kontogiannopoulos KN; Barmpalexis P
Mol Pharm; 2020 Jul; 17(7):2703-2720. PubMed ID: 32520564
[TBL] [Abstract][Full Text] [Related]
16. Atypical effects of incorporated surfactants on stability and dissolution properties of amorphous polymeric dispersions.
Al-Obaidi H; Lawrence MJ; Buckton G
J Pharm Pharmacol; 2016 Nov; 68(11):1373-1383. PubMed ID: 27696396
[TBL] [Abstract][Full Text] [Related]
17. Spray-Dried Amorphous Solid Dispersions of Griseofulvin in HPC/Soluplus/SDS: Elucidating the Multifaceted Impact of SDS as a Minor Component.
Rahman M; Ahmad S; Tarabokija J; Parker N; Bilgili E
Pharmaceutics; 2020 Feb; 12(3):. PubMed ID: 32106495
[TBL] [Abstract][Full Text] [Related]
18. Phase homogeneity in ternary amorphous solid dispersions and its impact on solubility, dissolution and supersaturation - Influence of processing and hydroxypropyl cellulose grade.
Pöstges F; Lenhart J; Stoyanov E; Lunter DJ; Wagner KG
Int J Pharm X; 2023 Dec; 6():100222. PubMed ID: 38162398
[TBL] [Abstract][Full Text] [Related]
19. Role of Surfactants on Release Performance of Amorphous Solid Dispersions of Ritonavir and Copovidone.
Indulkar AS; Lou X; Zhang GGZ; Taylor LS
Pharm Res; 2022 Feb; 39(2):381-397. PubMed ID: 35169959
[TBL] [Abstract][Full Text] [Related]
20. Boost of solubility and supersaturation of celecoxib via synergistic interactions of methacrylic acid-ethyl acrylate copolymer (1:1) and hydroxypropyl cellulose in ternary amorphous solid dispersions.
Pöstges F; Kayser K; Stoyanov E; Wagner KG
Int J Pharm X; 2022 Dec; 4():100115. PubMed ID: 35368508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
